MedTrace Logo

Registry Study of Medical Therapy in Patients With Angina Pectoris(GREAT)

NCT05050773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1556

Last updated 2023-08-01

No results posted yet for this study

Summary

The study will be a multi-center, prospective, cohort study based on registration of Chinese angina pectoris patients. After signing the informed consent, all patients will be screened as per the inclusion and exclusion criteria. Estimated 1500 eligible patients will be enrolled. Two natural cohort will be formed according to whether Nicorandil will be prescribed to patients or not. The baseline information of patients will be recorded and patients will be followed up to observe the effectiveness of different anti-angina regimens. Follow-up visits will be conducted at Month 3, 6, 9, 12 after enrollment. The visits at Months 3, 6 and 9 will be conducted in the form of electronic patient reported outcomes (ePRO) + telephone follow-up, and the visit at Month 12 will be conducted on site. Patients are required to fill in the patient diary records (weekly) during the course of the study.

This study is designed to establish a cohort of Chinese angina pectoris patients and compare the effectiveness of different anti-angina regimens in patients with angina pectoris.

Conditions

  • Angina Pectoris
  • Real World Study

Sponsors & Collaborators

  • Beijing Life oasis public service center

    collaborator UNKNOWN

  • Beijing Anzhen Hospital

    lead OTHER

Principal Investigators

  • Yong Zeng, MD · Anzhen hospital, Capital medical university

  • Xiliang Zhao, MD · Anzhen hospital, Capital medical university

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-13
Primary Completion
2023-06-10
Completion
2023-06-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05050773 on ClinicalTrials.gov